Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 3Xerostomia 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sexuality 1Sexual Dysfunction, Physiological 1Salivary Gland Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Breast Neoplasms 1

Interventions

Cetuximab 3Gemcitabine 2Gefitinib 2Biopsy 2vandetanib 1temsirolimus 1ficlatuzumab 1cediranib 1X-Rays 1Soybean Proteins 1Sirolimus 1Rhinoplasty 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Pilocarpine 1Pemetrexed 1Paclitaxel 1Optical Imaging 1Nivolumab 1Methods 1Metformin 1Lenalidomide 1Ipilimumab 1Independent Medical Evaluation 1Immunohistochemistry 1Educational Status 1Carboplatin 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoid Interstitial Pneumonia × Pilocarpine × Clear all
NCT00003139 2015-11-17

Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
249 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡